Australia’s Therapeutic Goods Administration (TGA) has issued a new safety alert for GLP-1 drugs—including Ozempic, Wegovy, Saxenda, Trulicity, and Mounjaro—highlighting potential risks of new or worsening depression, suicidal thoughts, and unusual mood changes.

The TGA acknowledged a complex relationship between medication effects, mental health, and rapid weight loss. The agency has received more than 70 reports of suicidal ideation and additional reports of suicide attempts or deaths among users.

MISSD believes all patients deserve truthful, transparent information about the risks of medication-induced symptoms that can lead to self-harm or suicide. Early recognition and accurate diagnosis of medication-induced akathisia and other adverse effects can save lives.

Read the full article at https://www.qoo10.co.id/en/international/50876/watchdog-updates-safety-warnings-on-ozempic-like-drugs-over-suicidal-thoughts-risk/.